CD19 and acute lymphoblastic leukemia: Immunophenotypic characterization of infant ALL and AML are distinct: KMT2A-r ALL is CD19- positive/CD10 negative and often co-express one or more myeloid antigens, suggesting that they are of the nature of immature lymphoid forerunners [10].